FRESH-PEF143-en
Arixtra and platelet monitoring (Study of the actual usage of Arixtra® 2, 5 mg in general practice
ARIANE
| Name |
|---|
| France |
Evaluate and compare in general practice the level of prescription for platelet monitoring of patients receiving Arixtra® 2.5 mg (fondaparinux sodium) or an LMWH (low-molecular-weight heparin) in venous thromboprophylaxis.
['Clinical data','Participant-reported health data']
Individuals
| Topic | Vocabulary | URI |
|---|---|---|
| cim-11 | http://id.who.int/icd/entity/864844707 | |
| Healthcare system determinants: Use of care | health determinant | |
| Healthcare system determinants | health determinant |
{
"level_sex_clusion_I": [
"Male",
"Female"
],
"level_age_clusion_I": [
"Young Adult (19 to 24 years)",
"Adult (25 to 44 years)",
"Middle Aged (45 to 64 years)",
"Aged (65 to 79 years)",
"Aged, 80 and over (80 years and more)"
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name |
|---|
| Christel Leclerc-Zwirn |
| Name | Role |
|---|---|
| GLAXOSMITHKLINE (FRANCE) | sponsor |
| Name |
|---|
| GLAXOSMITHKLINE (FRANCE) |
| Agency name |
|---|
| CNIL |
['Through independent healthcare practitioners']
['Other']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2008 | 2009 |
Cross-sectional study: one-time (excluding case-control studies)
Restricted access
| Name | |
|---|---|
| Christel Leclerc-Zwirn | christel.c.leclerc-zwirn@gsk.com |
FRESH-PEF143-en